Mesenchymal stromal cells (MSCs), also known as mesenchymal stem cells, have been
intensely investigated for clinical applications within the last decades. However, the majority …

The role of the mesenchymal stromal cell‐(MSC‐) derived secretome is becoming
increasingly intriguing from a clinical perspective due to its ability to stimulate endogenous …

Lymphedema affects up to 250 million people worldwide. The understanding of the
pathophysiology of the condition, however, is incomplete and a cure remains elusive. A …

Angiogenesis and lymphangiogenesis often occur in response to tissue injury or in the
presence of pathology (eg, cancer), and it is these types of environments in which …

Human adult mesenchymal stem cells (MSCs) support the engineering of functional tissue
constructs by secreting angiogenic and cytoprotective factors, which act in a paracrine …

Lymphedema is a common, complex, and inexplicably underappreciated human disease.
Despite a history of relative neglect by health care providers and by governmental health …

Mesenchymal stem cells (MSCs) are adult stem cells that hold great promise in the field of
regenerative medicine. They can be isolated from almost any tissue of the body and display …

CD34 is a cell surface antigen expressed in numerous stem/progenitor cells including
hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs), which are known …

Lymphedema affects up to 1 in 6 patients who undergo treatment for a solid tumor in the
United States. Its prevalence has increased as more effective oncologic therapies have …

The tremendous improvement of survival in patients with breast cancer can be attributed to
several treatment strategies, but these strategies also lead to the occurrence of breast …